Catalyst Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,833 | 0.0% | 164,212 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,320 | 0.0% | 66,988 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 5,863 | 0.0% | 270,171 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 5,720 | 0.0% | 235,872 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 2,071 | 0.0% | 99,213 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 2,410 | 0.0% | 121,222 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 1,316 | 0.0% | 84,976 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 2,058 | 0.0% | 129,101 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 3,069 | 0.0% | 182,543 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,590 | 0.0% | 135,972 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 2,536 | 0.0% | 188,674 | 6/30/2023 |
| 2023 Q1 | 5/16/2023 | 3,235 | 0.0% | 195,101 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 5,381 | 0.0% | 289,275 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 2,754 | 0.0% | 214,630 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 418 | 0.0% | 59,591 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 924 | 0.0% | 111,510 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 1,134 | 0.0% | 167,451 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,030 | 0.0% | 194,410 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 1,763 | 0.0% | 306,506 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 778 | 0.0% | 168,680 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 339 | 0.0% | 101,646 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 282 | 0.0% | 95,101 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 196 | 0.0% | 42,431 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 654 | 0.0% | 169,910 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 732 | 0.0% | 195,263 | 12/31/2019 |